
PMC:7228307 / 7888-7974
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
123 | 71-76 | Gene | denotes | FcγRI | Gene:2214 |
124 | 78-86 | Gene | denotes | FcγRIIIa | Gene:2214 |
134 | 62-69 | Gene | denotes | FcγRIIa | Gene:2212 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T127 | 62-64 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T128 | 71-73 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T129 | 78-80 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T33 | 74-76 | Chemical | denotes | RI | http://purl.obolibrary.org/obo/CHEBI_73814|http://purl.obolibrary.org/obo/CHEBI_8753 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
123 | 71-76 | Gene | denotes | FcγRI | Gene:2214 |
124 | 78-86 | Gene | denotes | FcγRIIIa | Gene:2214 |
134 | 62-69 | Gene | denotes | FcγRIIa | Gene:2212 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T41 | 0-86 | Sentence | denotes | Antigen presentation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 0-20 | http://purl.obolibrary.org/obo/GO_0019882 | denotes | Antigen presentation |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 0-20 | http://purl.obolibrary.org/obo/GO_0019882 | denotes | Antigen presentation |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 0-20 | http://purl.obolibrary.org/obo/GO_0019882 | denotes | Antigen presentation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T41 | 0-86 | Sentence | denotes | Antigen presentation Vaccine‐like immunity post‐mAb therapy FcγRIIa, FcγRI, FcγRIIIa |